Cherry Creek Investment Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$417K Sell
3,802
-52
-1% -$7.41K 0.18% 79
2025
Q4
$641K Buy
3,854
+200
+5% +$33.5K 0.27% 56
2025
Q3
$715K Buy
3,654
+693
+23% +$114K 0.31% 52
2025
Q2
$268K Sell
2,961
-586
-17% -$46.3K 0.13% 92
2025
Q1
$212K Buy
3,547
+534
+18% +$49.4K 0.11% 99
2024
Q4
$399K Buy
+3,013
New +$283K 0.2% 70
2024
Q3
Sell
-4,475
Closed -$271K 115
2024
Q2
$271K Buy
+4,475
New +$310K 0.14% 88

Other funds holding ALAB

Cherry Creek Investment Advisors's ALAB Position: Q1 2026 in Review

Cherry Creek Investment Advisors reduced its Astera Labs (ALAB) stake by 1.3% in Q1 2026, selling an estimated $7.41K and leaving 3,802 shares worth $417K. The position accounts for 0.18% of the portfolio, ranked #79.

Cherry Creek Investment Advisors first reported a position in ALAB in Q2 2024 and has held it in 7 quarters since. The position peaked at $715K in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Cherry Creek Investment Advisors held 3,802 shares of Astera Labs worth $417K as of Q1 2026.
  • Cherry Creek Investment Advisors sold 52 Astera Labs shares in Q1 2026, an estimated $7.41K.
  • Astera Labs made up 0.18% of Cherry Creek Investment Advisors's portfolio in Q1 2026, its #79 holding.
  • Cherry Creek Investment Advisors first reported a position in Astera Labs in Q2 2024 and has held it in 7 quarters since.
  • Cherry Creek Investment Advisors's Astera Labs position peaked at $715K in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Cherry Creek Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.